<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Inflammatory myofibroblastic tumor (plasma cell granuloma) of the lung</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Inflammatory myofibroblastic tumor (plasma cell granuloma) of the lung</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Inflammatory myofibroblastic tumor (plasma cell granuloma) of the lung</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Steven E Weinberger, MD, MACP, FRCP</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kevin R Flaherty, MD, MS</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Dieffenbach, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 20, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Inflammatory myofibroblastic tumor (IMT) of the lung (also known as plasma cell granuloma, inflammatory pseudotumor, fibrous histiocytoma, fibroxanthoma, and xanthogranuloma) includes a spectrum of pulmonary lesions. Such lesions most commonly present as solitary pulmonary nodules but can also be locally invasive [<a href="#rid1">1-5</a>]. The pathologic hallmark of these lesions is a proliferation of spindle cells with accompanying and admixed inflammatory cells [<a href="#rid6">6</a>]. It is unclear whether these lesions represent a primary inflammatory process versus a low-grade malignancy with a prominent inflammatory response.</p><p>Similar lesions, referred to variably in the literature as plasma cell granulomas or inflammatory pseudotumors, can also develop in the orbit, skull base, thyroid, liver, spine, spleen, lymph nodes, and other tissues [<a href="#rid1">1-3,7-12</a>]. (See  <a class="medical medical_review" href="/d/html/8386.html" rel="external">"Evaluation of peripheral lymphadenopathy in adults"</a> and  <a class="medical medical_review" href="/d/html/114329.html" rel="external">"Uncommon sarcoma subtypes"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>IMTs can occur in any age group, but over one-half of the patients are less than 40 years of age [<a href="#rid13">13,14</a>]. Although IMTs are rare in adults, comprising less than 1 percent of all surgically resected lung lesions, they do represent one of the most common primary lung tumors in the pediatric age group [<a href="#rid4">4,15-20</a>]. Both males and females and all ethnic groups appear to be equally affected.</p><p class="headingAnchor" id="H3"><span class="h1">PATHOLOGY</span><span class="headingEndMark"> — </span>There is significant controversy and confusion regarding the pathogenesis and histogenesis of these uncommon tumors or tumor-like masses  (<a class="graphic graphic_picture graphicRef81267" href="/d/graphic/81267.html" rel="external">picture 1</a>). Much of the confusion has been caused by the varying degrees of inflammatory cell infiltration noted on pathologic examination and the observation that the disease process, although usually following a benign course, is sometimes invasive. As a result, a variety of terms have been used to describe lesions falling under the category of IMT.</p><p>The early terminology "pulmonary plasma cell/histiocytoma complex" emphasized the histologic heterogeneity and a belief in the benign nature of the lesions [<a href="#rid21">21</a>]. Subsequently, plasma cell granuloma was the common terminology for lung lesions, acknowledging the circumscribed appearance, presence of plasma cells and histiocytes, and generally benign course. The term inflammatory pseudotumor was typically used to describe extrapulmonary lesions with similar pathology [<a href="#rid22">22-24</a>]. More malignant variants were felt to be analogous to undifferentiated "pleomorphic" sarcomas (previously termed malignant fibrous histiocytoma) arising in soft tissues. (See  <a class="medical medical_review" href="/d/html/14259.html" rel="external">"Clinical presentation, histopathology, diagnostic evaluation, and staging of soft tissue sarcoma", section on 'Histopathology'</a>.)</p><p>The most consistent pathologic feature of these lesions is a background proliferation of spindle cells associated with a variably dense polymorphic infiltrate of mononuclear inflammatory cells  (<a class="graphic graphic_picture graphicRef74480" href="/d/graphic/74480.html" rel="external">picture 2</a> and <a class="graphic graphic_picture graphicRef61654" href="/d/graphic/61654.html" rel="external">picture 3</a>) [<a href="#rid14">14</a>]. The spindle cells tend to be arranged in short fascicles with a focal storiform (whorled or cartwheel-like) architecture. Immunohistochemical and ultrastructural studies of the spindle cells show features of fibroblasts and myofibroblasts in various proportions [<a href="#rid24">24</a>]. Focal invasion, vascular invasion, and nuclear pleomorphism are all suggestive of more malignant behavior and a worse prognosis.</p><p>The inflammatory infiltrate is composed of a mixed population of lymphocytes, plasma cells, histiocytes, and occasional eosinophils and may be dense enough to obscure the underlying spindle cells [<a href="#rid24">24</a>]. Any individual cell type can predominate, although plasma cells and histiocytes tend to be the most conspicuous. Histiocytes may include multinucleated forms and frequently contain finely vacuolated cytoplasmic lipid droplets. Plasma cells may contain cytoplasmic Russell bodies (globular cytoplasmic inclusions of immunoglobulin) and demonstrate a polyclonal pattern of light chain expression. A nonspecific pattern of organizing pneumonia is frequently seen at the periphery of fibrous histiocytomas. Small vessel invasion can be demonstrated in some cases, and is of uncertain significance [<a href="#rid25">25</a>].</p><p class="headingAnchor" id="H4"><span class="h1">ETIOLOGY</span><span class="headingEndMark"> — </span>The etiology of IMT is unknown; theories include an inflammatory reaction to an infection or to an underlying low grade malignancy. Immunohistochemical staining of IMT reveals the presence of IgG-predominant, polyclonal plasma cells. This finding lends support to the theory that IMT is a reactive inflammatory process. Consistent with the reactive hypothesis is the observation that as many as one-third of these lesions have developed after a respiratory infection [<a href="#rid26">26,27</a>].</p><p>Several infectious agents have been linked to the development of IMT of the lung in specific patients, but these findings have not been noted universally. As examples, multiorgan disease has been noted in association with chronic persistent Eikenella corrodens infection, and some investigators have identified clonal DNA expression of Epstein Barr virus in extrapulmonary IMT [<a href="#rid2">2,9,10</a>].</p><p>Similarly, human herpes virus (HHV)-8 infection, which is linked to Kaposi's sarcoma and multicentric Castleman's disease, has also been proposed as a precipitant of IMT in the lung, based on identification of HHV-8 DNA within these lesions [<a href="#rid28">28,29</a>]. However, a number of cases have been negative for HHV-8 [<a href="#rid30">30</a>]. (See  <a class="medical medical_review" href="/d/html/8319.html" rel="external">"Human herpesvirus-8 infection"</a>.)</p><p>How an initial infection might lead to IMT is not well understood. Increased serum levels and increased local production of the cytokines interleukin-1 and interleukin-6 were demonstrated in one symptomatic patient, raising the possibility that the disease is initiated by dysregulation of cytokine production [<a href="#rid31">31</a>].</p><p>Another hypothesis, based upon detailed histopathological studies, is that some plasma cell granulomas are low-grade mesenchymal neoplasms with a secondary inflammatory component [<a href="#rid32">32</a>]. This is supported by the observation of a chromosomal rearrangement at band 2p23 in one-half to two-thirds of cases; this is the site of the anaplastic lymphoma kinase (ALK) gene in the tyrosine kinase locus [<a href="#rid14">14,23,33-36</a>]. Cytoplasmic expression of ALK has been noted in some IMT using immunohistochemistry. ALK mutations are found less commonly in pulmonary IMT than in extrapulmonary IMT [<a href="#rid30">30</a>]. ALK expression is abnormal outside the central nervous system. (See  <a class="medical medical_review" href="/d/html/4705.html" rel="external">"Clinical manifestations, pathologic features, and diagnosis of systemic anaplastic large cell lymphoma (sALCL)", section on 'ALK expression'</a>.)</p><p>A molecular mechanism for inflammatory myofibroblastic tumors has been suggested by a study reporting disruption of an RNA degradation pathway. In 13 of 15 samples of involved tissue from patients with these tumors, mutations were demonstrated in the UPF1 gene, which encodes an RNA helicase essential for nonsense-mediated RNA decay [<a href="#rid37">37</a>].</p><p class="headingAnchor" id="H5"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>The clinical features, including evidence of a preceding or concurrent respiratory infection, are variable. Approximately 70 percent of patients are asymptomatic [<a href="#rid26">26</a>]. Symptomatic patients may complain of cough, dyspnea, chest pain, or hemoptysis. Approximately 50 percent of patients have an elevated sedimentation rate, and mild anemia and thrombocytosis can also occur.</p><p class="headingAnchor" id="H6"><span class="h1">IMAGING</span><span class="headingEndMark"> — </span>IMT of the lung is detected by chest radiography, which generally shows a solitary, well-circumscribed mass or ill-defined, pneumonia-like density [<a href="#rid38">38</a>]. Focal calcifications, multiple nodules, and locally invasive disease have also been reported [<a href="#rid14">14,39</a>]. Usually, a chest computed tomography (CT) scan is obtained to clarify the extent of disease; however, there are no radiographic features that reliably differentiate IMT from other causes of pulmonary nodules. (18)F-2-deoxy-2-fluoro-D-glucose-positron emission tomography (FDG-PET) scans may show increased uptake [<a href="#rid40">40-42</a>]. </p><p class="headingAnchor" id="H7"><span class="h1">EVALUATION AND DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of IMT and differentiation from other malignant, infectious, and congenital lesions require histologic examination of tissue. The diagnosis is usually obtained with surgical resection, which is preferred since complete resection is almost always curative [<a href="#rid16">16</a>].</p><p>The diagnosis requires the presence of characteristic findings on histologic examination. The most consistent pathologic feature of these lesions is a background proliferation of spindle cells associated with a variably dense polymorphic infiltrate of mononuclear inflammatory cells [<a href="#rid14">14</a>]. (See <a class="local">'Pathology'</a> above.)</p><p>Attempts at fine needle aspiration have had some success, but have also yielded false positive and false negative results for the presence of carcinoma [<a href="#rid16">16,43</a>]. Bronchoscopy is rarely successful, because endobronchial IMT account for less than 5 percent of cases [<a href="#rid26">26,44,45</a>]. The diagnosis has rarely been made by transbronchial biopsy [<a href="#rid46">46</a>].</p><p class="headingAnchor" id="H8"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The pathologic differential diagnosis of IMT is lengthy and includes nonspecific inflammatory reactions secondary to various other conditions (eg, proximal airway obstruction, infection), cryptogenic organizing pneumonia (idiopathic bronchiolitis obliterans with organizing pneumonia), immunoglobulin G (IgG)-4-related disease, pseudolymphoma, small lymphocytic lymphomas, inflammatory sarcomatoid carcinomas, so-called inflammatory fibrosarcoma, and undifferentiated/unclassified or "pleomorphic" soft tissue sarcomas (previously termed malignant fibrous histiocytoma). Most of these diagnostic dilemmas can be resolved by careful attention to the bland cytologic features of IMT as well as by application of appropriate panels of immunostains to difficult cases [<a href="#rid14">14,24,47</a>].</p><p class="headingAnchor" id="H9"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>Complete surgical resection is the treatment of choice for IMT [<a href="#rid13">13,22,23,27,39,45,48-52</a>]. Depending on local expertise, this may be accomplished by video-assisted thoracoscopy or open thoracotomy; larger lesions and those with evidence of local invasion of adjacent tissues will likely require a thoracotomy. Frozen section examination is helpful in guiding the extent of excision, which is generally minimized to preserve lung function [<a href="#rid53">53</a>]. The thrombocytosis associated with IMT has been reported to regress after surgical resection [<a href="#rid54">54</a>].</p><p>For patients who are unable to have complete surgical resection (eg, poor surgical candidates, multiple nodules, or unresectable disease), nonsurgical modalities may be used. There are anecdotal reports of both success and failure with glucocorticoids, radiotherapy, and chemotherapy [<a href="#rid16">16,33,46</a>]. </p><p>A potential form of therapy for IMT has been described that uses a competitive inhibitor of the anaplastic lymphoma kinase (ALK) tyrosine kinase, called <a class="drug drug_general" data-topicid="16810" href="/d/drug information/16810.html" rel="external">crizotinib</a> (see <a class="local">'Etiology'</a> above) [<a href="#rid35">35,55-59</a>]. In an initial case report, crizotinib appeared to be beneficial in a patient with rearrangements in the ALK gene, but not in a patient without such rearrangement [<a href="#rid35">35</a>]. A subsequent review of 32 patients with IMT (including its subtype epithelioid inflammatory myofibroblastic sarcoma) found that 12 patients had complete or partial remission with crizotinib; however, there was incomplete information about ALK status and duration of follow-up in some of the reported patients [<a href="#rid60">60</a>]. (See  <a class="medical medical_review" href="/d/html/114329.html" rel="external">"Uncommon sarcoma subtypes", section on 'Inflammatory myofibroblastic tumor'</a>.)</p><p class="headingAnchor" id="H10"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>The natural history of IMT is somewhat variable. The lesions typically remain stable in size or grow slowly, and some have regressed spontaneously after open biopsy [<a href="#rid13">13,32,53</a>]. Most patients are cured with complete surgical resection [<a href="#rid51">51,61</a>]. However, some lesions become locally invasive and involve the mediastinum, diaphragm, chest wall, vertebral bodies, heart, and major vessels [<a href="#rid16">16,62,63</a>]. Complete tumor excision and tumor size ≤3 cm are factors associated with a decreased risk of recurrence [<a href="#rid22">22</a>].</p><p>Long-term follow-up is recommended for patients who have undergone surgery, as recurrent tumors have been reported as long as 11 years after resection [<a href="#rid64">64,65</a>].</p><p class="headingAnchor" id="H11"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview</strong> – Inflammatory myofibroblastic tumor (IMT) of the lung (also known as plasma cell granuloma, inflammatory pseudotumor, fibrous histiocytoma, fibroxanthoma, and xanthogranuloma) includes lesions with a spectrum of pulmonary manifestations, from the more common solitary pulmonary nodules to the rare locally invasive tumors or multiple nodules. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathology</strong> – The consistent pathologic feature of IMT is a background proliferation of spindle cells associated with a variably dense polymorphic infiltrate of mononuclear inflammatory cells (eg, lymphocytes, plasma cells, histiocytes, and occasional eosinophils). (See <a class="local">'Pathology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – The clinical features are variable. Patients may be asymptomatic or may have cough, dyspnea, chest pain, or hemoptysis. Some may report a preceding or concurrent respiratory infection. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Imaging</strong> – IMT in the lung is detected by chest radiograph, which generally shows a solitary, well-circumscribed mass or ill-defined, pneumonia-like density. Less commonly, more than one nodule or evidence of locally invasive disease may be noted. (See <a class="local">'Imaging'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – Histologic examination of tissue is needed to make the diagnosis of IMT of the lung. Usually, this is obtained during surgical resection by open thoracotomy or video-assisted thoracoscopic surgery. The choice between these options depends on the size and location of the nodule, and whether there is local invasion of adjacent tissues. (See <a class="local">'Evaluation and diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong> – We recommend complete surgical resection of IMT of the lung in the majority of patients (<a class="grade" href="https://medilib.ir/uptodate/show/grade_2" rel="external">Grade 1B</a>). (See <a class="local">'Treatment'</a> above.)</p><p></p><p class="bulletIndent1">For patients who are unable to have complete surgical resection (eg, poor surgical candidates, multiple nodules, or unresectable disease) glucocorticoids, radiotherapy, and chemotherapy have been used with variable success. For patients with IMT who have anaplastic lymphoma kinase (ALK) rearrangements and multifocal disease or are otherwise not surgical candidates, preliminary data suggest that <a class="drug drug_general" data-topicid="16810" href="/d/drug information/16810.html" rel="external">crizotinib</a> may be beneficial. (See <a class="local">'Etiology'</a> above and <a class="local">'Treatment'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Mahr MA, Salomao DR, Garrity JA. Inflammatory orbital pseudotumor with extension beyond the orbit. Am J Ophthalmol 2004; 138:396.</a></li><li><a class="nounderline abstract_t">Buccoliero AM, Caldarella A, Santucci M, et al. Plasma cell granuloma--an enigmatic lesion: description of an extensive intracranial case and review of the literature. Arch Pathol Lab Med 2003; 127:e220.</a></li><li><a class="nounderline abstract_t">Martinez F, Filipowicz E, Hudnall SD. Plasma cell granuloma of the thyroid. Arch Pathol Lab Med 2002; 126:595.</a></li><li><a class="nounderline abstract_t">Nonomura A, Mizukami Y, Matsubara F, et al. Seven patients with plasma cell granuloma (inflammatory pseudotumor) of the lung, including two with intrabronchial growth: an immunohistochemical and electron microscopic study. Intern Med 1992; 31:756.</a></li><li><a class="nounderline abstract_t">Surabhi VR, Chua S, Patel RP, et al. Inflammatory Myofibroblastic Tumors: Current Update. Radiol Clin North Am 2016; 54:553.</a></li><li><a class="nounderline abstract_t">Sagar AES, Jimenez CA, Shannon VR. Clinical and Histopathologic Correlates and Management Strategies for Inflammatory Myofibroblastic tumor of the lung. A case series and review of the literature. Med Oncol 2018; 35:102.</a></li><li><a class="nounderline abstract_t">Koea JB, Broadhurst GW, Rodgers MS, McCall JL. Inflammatory pseudotumor of the liver: demographics, diagnosis, and the case for nonoperative management. J Am Coll Surg 2003; 196:226.</a></li><li><a class="nounderline abstract_t">Aizawa T, Sato T, Tanaka Y, et al. Intramedullary plasma cell granuloma in the cervicothoracic spine. Case report. J Neurosurg 2002; 97:235.</a></li><li><a class="nounderline abstract_t">Lewis JT, Gaffney RL, Casey MB, et al. Inflammatory pseudotumor of the spleen associated with a clonal Epstein-Barr virus genome. Case report and review of the literature. Am J Clin Pathol 2003; 120:56.</a></li><li><a class="nounderline abstract_t">Lee SH, Fang YC, Luo JP, et al. Inflammatory pseudotumour associated with chronic persistent Eikenella corrodens infection: a case report and brief review. J Clin Pathol 2003; 56:868.</a></li><li><a class="nounderline abstract_t">Ceruse P, Ramade A, Vautrin R, et al. Inflammatory pseudotumor of the neck: a long-term result without surgical approach. Otolaryngol Head Neck Surg 2005; 132:812.</a></li><li><a class="nounderline abstract_t">Patnana M, Sevrukov AB, Elsayes KM, et al. Inflammatory pseudotumor: the great mimicker. AJR Am J Roentgenol 2012; 198:W217.</a></li><li><a class="nounderline abstract_t">Kim JH, Cho JH, Park MS, et al. Pulmonary inflammatory pseudotumor--a report of 28 cases. Korean J Intern Med 2002; 17:252.</a></li><li><a class="nounderline abstract_t">Lai LM, McCarville MB, Kirby P, et al. Shedding light on inflammatory pseudotumor in children: spotlight on inflammatory myofibroblastic tumor. Pediatr Radiol 2015; 45:1738.</a></li><li><a class="nounderline abstract_t">Vancauwenbergh A, Smet MH, Breysem L. Inflammatory pseudotumor of the lung. JBR-BTR 2002; 85:209.</a></li><li><a class="nounderline abstract_t">Urschel JD, Horan TA, Unruh HW. Plasma cell granuloma of the lung. J Thorac Cardiovasc Surg 1992; 104:870.</a></li><li><a class="nounderline abstract_t">Ishida T, Oka T, Nishino T, et al. Inflammatory pseudotumor of the lung in adults: radiographic and clinicopathological analysis. Ann Thorac Surg 1989; 48:90.</a></li><li><a class="nounderline abstract_t">Lebecque P, Lapierre JG, Brochu P, et al. Pulmonary plasma cell granuloma. Eur J Pediatr 1987; 146:174.</a></li><li><a class="nounderline abstract_t">Pettinato G, Manivel JC, De Rosa N, Dehner LP. Inflammatory myofibroblastic tumor (plasma cell granuloma). Clinicopathologic study of 20 cases with immunohistochemical and ultrastructural observations. Am J Clin Pathol 1990; 94:538.</a></li><li><a class="nounderline abstract_t">Souid AK, Ziemba MC, Dubansky AS, et al. Inflammatory myofibroblastic tumor in children. Cancer 1993; 72:2042.</a></li><li><a class="nounderline abstract_t">Spencer H. The pulmonary plasma cell/histiocytoma complex. Histopathology 1984; 8:903.</a></li><li><a class="nounderline abstract_t">Melloni G, Carretta A, Ciriaco P, et al. Inflammatory pseudotumor of the lung in adults. Ann Thorac Surg 2005; 79:426.</a></li><li><a class="nounderline abstract_t">Sakurai H, Hasegawa T, Watanabe Si, et al. Inflammatory myofibroblastic tumor of the lung. Eur J Cardiothorac Surg 2004; 25:155.</a></li><li class="breakAll">World Health Organization Classification of Tumors. Pathology and Genetics of the Lung, Pleura, Thymus, and Heart, Travis, WD, Brambilla, E, Muller-Hermelink, HK, et al (Eds), IARC Press, Lyon 2004.</li><li><a class="nounderline abstract_t">Warter A, Satge D, Roeslin N. Angioinvasive plasma cell granulomas of the lung. Cancer 1987; 59:435.</a></li><li><a class="nounderline abstract_t">Berardi RS, Lee SS, Chen HP, Stines GJ. Inflammatory pseudotumors of the lung. Surg Gynecol Obstet 1983; 156:89.</a></li><li><a class="nounderline abstract_t">Matsubara O, Tan-Liu NS, Kenney RM, Mark EJ. Inflammatory pseudotumors of the lung: progression from organizing pneumonia to fibrous histiocytoma or to plasma cell granuloma in 32 cases. Hum Pathol 1988; 19:807.</a></li><li><a class="nounderline abstract_t">Gómez-Román JJ, Sánchez-Velasco P, Ocejo-Vinyals G, et al. Human herpesvirus-8 genes are expressed in pulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). Am J Surg Pathol 2001; 25:624.</a></li><li><a class="nounderline abstract_t">Gómez-Román JJ, Ocejo-Vinyals G, Sánchez-Velasco P, et al. Presence of human herpesvirus-8 DNA sequences and overexpression of human IL-6 and cyclin D1 in inflammatory myofibroblastic tumor (inflammatory pseudotumor). Lab Invest 2000; 80:1121.</a></li><li><a class="nounderline abstract_t">Tavora F, Shilo K, Ozbudak IH, et al. Absence of human herpesvirus-8 in pulmonary inflammatory myofibroblastic tumor: immunohistochemical and molecular analysis of 20 cases. Mod Pathol 2007; 20:995.</a></li><li><a class="nounderline abstract_t">Rohrlich P, Peuchmaur M, Cocci SN, et al. Interleukin-6 and interleukin-1 beta production in a pediatric plasma cell granuloma of the lung. Am J Surg Pathol 1995; 19:590.</a></li><li><a class="nounderline abstract_t">Gal AA, Koss MN, McCarthy WF, Hochholzer L. Prognostic factors in pulmonary fibrohistiocytic lesions. Cancer 1994; 73:1817.</a></li><li><a class="nounderline abstract_t">Kovach SJ, Fischer AC, Katzman PJ, et al. Inflammatory myofibroblastic tumors. J Surg Oncol 2006; 94:385.</a></li><li><a class="nounderline abstract_t">Lawrence B, Perez-Atayde A, Hibbard MK, et al. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol 2000; 157:377.</a></li><li><a class="nounderline abstract_t">Butrynski JE, D'Adamo DR, Hornick JL, et al. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med 2010; 363:1727.</a></li><li><a class="nounderline abstract_t">Coffin CM, Patel A, Perkins S, et al. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol 2001; 14:569.</a></li><li><a class="nounderline abstract_t">Lu J, Plank TD, Su F, et al. The nonsense-mediated RNA decay pathway is disrupted in inflammatory myofibroblastic tumors. J Clin Invest 2016; 126:3058.</a></li><li><a class="nounderline abstract_t">Narla LD, Newman B, Spottswood SS, et al. Inflammatory pseudotumor. Radiographics 2003; 23:719.</a></li><li><a class="nounderline abstract_t">Kato S, Kondo K, Teramoto T, et al. A case report of inflammatory pseudotumor of the lung: rapid recurrence appearing as multiple lung nodules. Ann Thorac Cardiovasc Surg 2002; 8:224.</a></li><li><a class="nounderline abstract_t">van den Heuvel DA, Keijsers RG, van Es HW, et al. Invasive inflammatory myofibroblastic tumor of the lung. J Thorac Oncol 2009; 4:923.</a></li><li><a class="nounderline abstract_t">Dua SG, Purandare N, Pramesh CS, et al. Fluoro-deoxy glucose-avid endobronchial inflammatory myofibroblastic tumor mimicking bronchial malignancy: report of a case. J Cancer Res Ther 2011; 7:340.</a></li><li><a class="nounderline abstract_t">Dong A, Wang Y, Dong H, et al. Inflammatory myofibroblastic tumor: FDG PET/CT findings with pathologic correlation. Clin Nucl Med 2014; 39:113.</a></li><li><a class="nounderline abstract_t">Kushihashi T, Munechika H, Satou S, et al. [CT findings of pulmonary inflammatory pseudotumors (plasma cell granulomas)]. Nihon Igaku Hoshasen Gakkai Zasshi 1994; 54:13.</a></li><li><a class="nounderline abstract_t">Oteo Domínguez JF, Yebra Bango M, Varela de Ugarte A, et al. [Endobronchial inflammatory pseudotumor. A case report and review of the literature]. Arch Bronconeumol 1994; 30:52.</a></li><li><a class="nounderline abstract_t">Thistlethwaite PA, Renner J, Duhamel D, et al. Surgical management of endobronchial inflammatory myofibroblastic tumors. Ann Thorac Surg 2011; 91:367.</a></li><li><a class="nounderline abstract_t">Bando T, Fujimura M, Noda Y, et al. Pulmonary plasma cell granuloma improves with corticosteroid therapy. Chest 1994; 105:1574.</a></li><li><a class="nounderline abstract_t">Barbareschi M, Ferrero S, Aldovini D, et al. Inflammatory pseudotumour of the lung. Immunohistochemical analysis on four new cases. Histol Histopathol 1990; 5:205.</a></li><li><a class="nounderline abstract_t">Daudi FA, Lees GM, Higa TE. Inflammatory pseudotumours of the lung: two cases and a review. Can J Surg 1991; 34:461.</a></li><li><a class="nounderline abstract_t">Dahabreh J, Zisis C, Arnogiannaki N, Katis K. Inflammatory pseudotumor: a controversial entity. Eur J Cardiothorac Surg 1999; 16:670.</a></li><li><a class="nounderline abstract_t">Cerfolio RJ, Matthews TC. Resection of the entire left mainstem bronchus for an inflammatory pseudotumor. Ann Thorac Surg 2005; 79:2127.</a></li><li><a class="nounderline abstract_t">Fabre D, Fadel E, Singhal S, et al. Complete resection of pulmonary inflammatory pseudotumors has excellent long-term prognosis. J Thorac Cardiovasc Surg 2009; 137:435.</a></li><li><a class="nounderline abstract_t">Debonis SA, Bongiovanni A, Pieri F, et al. ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterations. Medicine (Baltimore) 2021; 100:e25972.</a></li><li><a class="nounderline abstract_t">Mandelbaum I, Brashear RE, Hull MT. Surgical treatment and course of pulmonary pseudotumor (plasma cell granuloma). J Thorac Cardiovasc Surg 1981; 82:77.</a></li><li><a class="nounderline abstract_t">Venuta F, Rendina EA, Pompeo E, et al. Regression of autoimmune thrombocythemia after resection of pulmonary plasma cell granuloma. J Thorac Cardiovasc Surg 1994; 108:393.</a></li><li><a class="nounderline abstract_t">Christensen JG, Zou HY, Arango ME, et al. Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma. Mol Cancer Ther 2007; 6:3314.</a></li><li><a class="nounderline abstract_t">Zou HY, Li Q, Lee JH, et al. An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms. Cancer Res 2007; 67:4408.</a></li><li><a class="nounderline abstract_t">Mossé YP, Lim MS, Voss SD, et al. Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study. Lancet Oncol 2013; 14:472.</a></li><li><a class="nounderline abstract_t">Gambacorti-Passerini C, Orlov S, Zhang L, et al. Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study. Am J Hematol 2018; 93:607.</a></li><li><a class="nounderline abstract_t">Schöffski P, Sufliarsky J, Gelderblom H, et al. Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial. Lancet Respir Med 2018; 6:431.</a></li><li><a class="nounderline abstract_t">Theilen TM, Soerensen J, Bochennek K, et al. Crizotinib in ALK+ inflammatory myofibroblastic tumors-Current experience and future perspectives. Pediatr Blood Cancer 2018; 65.</a></li><li><a class="nounderline abstract_t">Chen CH, Huang WC, Liu HC, et al. Surgical outcome of inflammatory pseudotumor in the lung. Thorac Cardiovasc Surg 2008; 56:214.</a></li><li><a class="nounderline abstract_t">Berman M, Georghiou GP, Schonfeld T, et al. Pulmonary inflammatory myofibroblastic tumor invading the left atrium. Ann Thorac Surg 2003; 76:601.</a></li><li><a class="nounderline abstract_t">Corneli G, Alifano M, Forti Parri S, et al. Invasive inflammatory pseudo-tumor involving the lung and the mediastinum. Thorac Cardiovasc Surg 2001; 49:124.</a></li><li><a class="nounderline abstract_t">Weinberg PB, Bromberg PA, Askin FB. "Recurrence" of a plasma cell granuloma 11 years after initial resection. South Med J 1987; 80:519.</a></li><li><a class="nounderline abstract_t">Cerfolio RJ, Allen MS, Nascimento AG, et al. Inflammatory pseudotumors of the lung. Ann Thorac Surg 1999; 67:933.</a></li></ol></div><div id="topicVersionRevision">Topic 4352 Version 23.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15364221" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Inflammatory orbital pseudotumor with extension beyond the orbit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12683907" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Plasma cell granuloma--an enigmatic lesion: description of an extensive intracranial case and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11958667" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Plasma cell granuloma of the thyroid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1392177" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Seven patients with plasma cell granuloma (inflammatory pseudotumor) of the lung, including two with intrabronchial growth: an immunohistochemical and electron microscopic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27153788" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Inflammatory Myofibroblastic Tumors: Current Update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29869302" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Clinical and Histopathologic Correlates and Management Strategies for Inflammatory Myofibroblastic tumor of the lung. A case series and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12595051" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Inflammatory pseudotumor of the liver: demographics, diagnosis, and the case for nonoperative management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12296686" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Intramedullary plasma cell granuloma in the cervicothoracic spine. Case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12866373" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Inflammatory pseudotumor of the spleen associated with a clonal Epstein-Barr virus genome. Case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14600136" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Inflammatory pseudotumour associated with chronic persistent Eikenella corrodens infection: a case report and brief review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15886643" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Inflammatory pseudotumor of the neck: a long-term result without surgical approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22358018" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Inflammatory pseudotumor: the great mimicker.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12647641" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Pulmonary inflammatory pseudotumor--a report of 28 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25964134" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Shedding light on inflammatory pseudotumor in children: spotlight on inflammatory myofibroblastic tumor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12403391" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Inflammatory pseudotumor of the lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1405683" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Plasma cell granuloma of the lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2764605" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Inflammatory pseudotumor of the lung in adults: radiographic and clinicopathological analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3569355" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Pulmonary plasma cell granuloma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2239820" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Inflammatory myofibroblastic tumor (plasma cell granuloma). Clinicopathologic study of 20 cases with immunohistochemical and ultrastructural observations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8364883" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Inflammatory myofibroblastic tumor in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6098549" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The pulmonary plasma cell/histiocytoma complex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15680808" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Inflammatory pseudotumor of the lung in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14747105" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Inflammatory myofibroblastic tumor of the lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14747105" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Inflammatory myofibroblastic tumor of the lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2431760" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Angioinvasive plasma cell granulomas of the lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6336632" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Inflammatory pseudotumors of the lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2841219" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Inflammatory pseudotumors of the lung: progression from organizing pneumonia to fibrous histiocytoma or to plasma cell granuloma in 32 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11342774" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Human herpesvirus-8 genes are expressed in pulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10908158" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Presence of human herpesvirus-8 DNA sequences and overexpression of human IL-6 and cyclin D1 in inflammatory myofibroblastic tumor (inflammatory pseudotumor).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17643094" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Absence of human herpesvirus-8 in pulmonary inflammatory myofibroblastic tumor: immunohistochemical and molecular analysis of 20 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7726369" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Interleukin-6 and interleukin-1 beta production in a pediatric plasma cell granuloma of the lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8137205" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Prognostic factors in pulmonary fibrohistiocytic lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16967468" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Inflammatory myofibroblastic tumors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10934142" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20979472" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11406658" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27348585" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : The nonsense-mediated RNA decay pathway is disrupted in inflammatory myofibroblastic tumors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12740472" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Inflammatory pseudotumor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12472387" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : A case report of inflammatory pseudotumor of the lung: rapid recurrence appearing as multiple lung nodules.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19550247" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Invasive inflammatory myofibroblastic tumor of the lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22044819" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Fluoro-deoxy glucose-avid endobronchial inflammatory myofibroblastic tumor mimicking bronchial malignancy: report of a case.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23797227" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Inflammatory myofibroblastic tumor: FDG PET/CT findings with pathologic correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8121766" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : [CT findings of pulmonary inflammatory pseudotumors (plasma cell granulomas)].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8149076" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : [Endobronchial inflammatory pseudotumor. A case report and review of the literature].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21256271" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Surgical management of endobronchial inflammatory myofibroblastic tumors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8181356" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Pulmonary plasma cell granuloma improves with corticosteroid therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2134374" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Inflammatory pseudotumour of the lung. Immunohistochemical analysis on four new cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1913390" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Inflammatory pseudotumours of the lung: two cases and a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10647841" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Inflammatory pseudotumor: a controversial entity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15919323" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Resection of the entire left mainstem bronchus for an inflammatory pseudotumor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19185166" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Complete resection of pulmonary inflammatory pseudotumors has excellent long-term prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34011083" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7242136" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Surgical treatment and course of pulmonary pseudotumor (plasma cell granuloma).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8041196" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Regression of autoimmune thrombocythemia after resection of pulmonary plasma cell granuloma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18089725" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17483355" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23598171" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29352732" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29669701" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29286567" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Crizotinib in ALK+ inflammatory myofibroblastic tumors-Current experience and future perspectives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18481240" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Surgical outcome of inflammatory pseudotumor in the lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12902113" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Pulmonary inflammatory myofibroblastic tumor invading the left atrium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11339451" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Invasive inflammatory pseudo-tumor involving the lung and the mediastinum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3563587" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : "Recurrence" of a plasma cell granuloma 11 years after initial resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10320231" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Inflammatory pseudotumors of the lung.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
